A structured, phenotype-driven anesthetic approach may reduce ischemic events and improve outcomes in patients with coronary vasomotor dysfunction undergoing noncardiac surgery.
A structured, phenotype-driven anesthetic approach may reduce ischemic events and improve outcomes in patients with coronary vasomotor dysfunction undergoing noncardiac surgery.
Absolute Event Rate: 0% vs 0%
CVDys is particularly prevalent in females and often associated with atypical symptoms, diagnostic delay, psychological burden, and impaired quality of life. A structured, phenotype‑driven anesthetic approach - prioritizing stable hemodynamics, avoidance of vascular spasm triggers, preservation of euvolemia and oxygen delivery, multimodal analgesia, perioperative stress reduction, early recognition of ischemic symptoms, and close collaboration with cardiology - may reduce ischemic events and improve outcomes in this high risk but frequently overlooked population.
Strypet et al. (Thu,) reported a other. A structured, phenotype-driven anesthetic approach may reduce ischemic events and improve outcomes in patients with coronary vasomotor dysfunction undergoing noncardiac surgery.